Showing results (1-10 of 212) with videos related to
Sort By:
Pageof 22
Rheumatic Diseases Clinics of North America|July 3, 2021
Treatment Update in Systemic Lupus ErythematousAlberta Y Hoi, Eric F MorandThe Journal of Rheumatology|January 17, 2017
Quality of Care for Systemic Lupus Erythematosus: Mind the Knowledge GapVera Golder, Eric F Morand, Alberta Y HoiImmunology and Cell Biology|September 13, 2003
Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus?Alberta Y Hoi, Eric F Morand, Michelle LeechInflammation & Allergy Drug Targets|September 28, 2007
Macrophage migration inhibitory factor: a therapeutic target across inflammatory diseasesAlberta Y Hoi, Magdy N Iskander, Eric F MorandLupus Science & Medicine|December 8, 2017
Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us?Daniel Boulos, Rachel L Koelmeyer, Eric F Morand, et al.Clinical & Translational Immunology|April 27, 2019
Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosusFabien B Vincent, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.Lupus Science & Medicine|June 18, 2020
Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosusFabien B Vincent, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.Journal of Translational Autoimmunity|September 22, 2025
Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatmentZhi Feng Sherman Lim, Alberta Y Hoi, Fabien B Vincent, et al.Lupus Science & Medicine|November 7, 2018
Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosusFabien B Vincent, Laura Slavin, Alberta Y Hoi, et al.RMD Open|July 15, 2026
Serum IgA autoantibody profiling in systemic lupus erythematosus reveals associations with disease phenotypesLaura E Eades, Artemis Papadaki, Katie Lennard, et al.Pageof 22